SCHEMBL7461577

SCHEMBL7461577

Cc1cc2c(cc1-c1ccc(/C=C3\SC(=O)NC3=O)cc1N(C)C)C(C)(C)CCC2(C)C

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.49
PIM1 P11309 11/20 0.49
PIM2 Q9P1W9 11/20 0.49
HPGD P15428 1/20 0.46
AKR1B1 P15121 4/20 0.44
RXRA P19793 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
PIM3 Q86V86 2/20 0.43
PDE4B Q07343 1/20 0.43
IGF1R P08069 1/20 0.43
CISD1 Q9NZ45 2/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
PARP1 P09874 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7461584 1.00 GSK3B (0.49) GSK3BPIM1PIM2HPGDAKR1B1
SCHEMBL7457146 0.92 PIM1 (0.52) GSK3BPIM1PIM2HPGDAKR1B1
SCHEMBL7457143 0.92 PIM1 (0.52) GSK3BPIM1PIM2HPGDAKR1B1
SCHEMBL5492867 0.92 GSK3B (0.49) GSK3BPIM1PIM2HPGDAKR1B1
SCHEMBL5492870 0.92 GSK3B (0.49) GSK3BPIM1PIM2HPGDAKR1B1
SCHEMBL14492755 0.92 GSK3B (0.49) GSK3BPIM1PIM2HPGDAKR1B1
SCHEMBL7458010 0.89 PIM1 (0.52) GSK3BPIM1PIM2HPGDAKR1B1
SCHEMBL7458015 0.89 PIM1 (0.52) GSK3BPIM1PIM2HPGDAKR1B1
SCHEMBL14492757 0.87 PIM1 (0.52) GSK3BPIM1PIM2HPGDAKR1B1
SCHEMBL5487591 0.87 PIM1 (0.52) GSK3BPIM1PIM2HPGDAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214305-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION Maxia Pharmaceuticals, Inc. (US) 2002-06-19 EP claimed
WO-2001016123-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION MAXIA PHARMACEUTICALS, INC. (US) 2001-03-08 WO claimed
EP-1214305-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION Maxia Pharmaceuticals, Inc. (US) 2002-06-19 EP disclosed
WO-2001016123-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION MAXIA PHARMACEUTICALS, INC. (US) 2001-03-08 WO disclosed